Lessons from the withdrawal of rofecoxib: France has policy for overall assessment of public health impact of new drugs

相似書籍

• Lessons from the withdrawal of rofecoxib: Observational studies should not be forgotten
  由: Oakley, Godfrey
  出版: (2004)
• Lessons from the withdrawal of rofecoxib: Patients would be safer if drug companies disclosed adverse events before licensing
  由: Dieppe, Paul A, et al.
  出版: (2004)
• Lawsuits mount in wake of rofecoxib (Vioxx) withdrawal
  由: Kondro, Wayne
  出版: (2004)
• Health Impact Assessment: Necessary but Not Sufficient for Healthy Public Policy
  由: Gottlieb, Laura M., et al.
  出版: (2012)
• The impact of influenza vaccination on the COVID-19 pandemic? Evidence and lessons for public health policies
  由: Paget, John, et al.
  出版: (2020)